Research & Development
Influenza: Page 2
CorDX obtains CE Mark for test for COVID-19, flu A/B, RSV
"As COVID-19 infection prevention measures relax globally, COVID and other viral infections are projected to rise," CorDx founder and CEO Jeff Yufeng Li said in a statement.
June 2, 2022
Seegene unveils strategy for $12 COVID-19 PCR tests
The company's "in-life PCR" initiative includes asymptomatic testing for early virus detection and syndromic respiratory testing, as well as boosting PCR test accessibility through affordable pricing.
May 24, 2022
LabPulse.com Microbiology Insider
Dear Microbiology Insider,
May 17, 2022
Visby awarded $25M to develop combined flu-COVID test
The funds were awarded by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) and will support continued development of the test. As it is, the company's Flu-COVID PCR test is a single-use, handheld, and all-in-one PCR device that detects and distinguishes between influenza A, influenza B, and SARS-CoV-2 from one sample.
March 27, 2022
Visby raises $100M in financing
The funds will be used to scale production capacity from tens to hundreds of thousands of tests per month, to expand its product portfolio to include COVID plus influenza A/B combination testing and antimicrobial resistance panels, and to deliver PCR diagnostics to consumers at-home.
March 2, 2022
Roche adds SARS-CoV-2 tests to new Cobas 5800 systems
The expansion will see the Cobas SARS-CoV-2 Qualitative and Cobas SARS-CoV-2 and Influenza A/B tests included in the Cobas 5800 system, a recently launched molecular laboratory instrument.
February 23, 2022
DNA forensic evidence frees Ohio man of rape, attempted rape
‘Good’ cholesterol worse for some adults: NIH study
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
DnaNudge launches 90-minute COVID test in Australia
CovidNudge is a point-of-care test platform that consists of the DnaCartridge, a disposable and sealed lab-on-chip device, and the NudgeBox, a standalone instrument that is connected to the DnaNudge Cloud for processing.
February 15, 2022
Smartphone-based LAMP assay can detect COVID, flu
Smart LAMP is portable and inexpensive to set up (less than $100, according to the authors) and consists of a hot plate, cardboard box, and LED lights. The researchers designed the diagnostic to meet five criteria for rapid and frequent testing at the point of care: speed, sensitivity, low cost, scalability, and accessibility. The assay simultaneously analyzes up to 96 saliva samples per phone at a cost of less than $7 per test, the researchers noted.
January 27, 2022
MilliporeSigma secures $137M contract from U.S. government
The award will cover a three-year period and is from the U.S. Department of Defense, on behalf of the U.S. Department of Health and Human Services; it is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness, the company said in a press release.
January 3, 2022
Applied BioCode receives EUA for SARS-CoV-2 combo assay
The assay can simultaneously detect and differentiate between SARS-CoV-2, influenza A with subtypes, and respiratory syncytial virus in nasopharyngeal swab specimens, the company said. The test is designed to assist physicians in evaluating patients with clinical signs and symptoms of respiratory infection.
December 16, 2021
Eurofins launches assay to detect omicron variant of COVID
Called GSD NovaType Detect + Select K417N SARS-CoV-2, the assay is designed for simultaneous qualitative detection of SARS-CoV-2 genomic RNA and identification of the spike mutation K417N in one reaction. The company said results can be obtained within one hour.
December 2, 2021
Eurofins debuts 2 combined tests for COVID/influenza, RSV
The new multiplex kits have been granted the CE Mark and are designed to detect and differentiate three viral infections in the same PCR run, Eurofins said.
November 30, 2021
Page 2 of 6